|
EIF2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.05470000000019E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18779999999752E-05 |
| Normal-vs-Stage2 |
1.368030E-02 |
| Normal-vs-Stage3 |
1.071000E-01 |
| Normal-vs-Stage4 |
7.252400E-01 |
| Stage1-vs-Stage2 |
6.097200E-01 |
| Stage1-vs-Stage3 |
2.475800E-01 |
| Stage1-vs-Stage4 |
1.487840E-01 |
| Stage2-vs-Stage3 |
6.258800E-01 |
| Stage2-vs-Stage4 |
2.328400E-01 |
| Stage3-vs-Stage4 |
3.365000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.03019999999566E-05 |
| Normal-vs-AfricanAmerican |
4.041500E-03 |
| Normal-vs-Asian |
4.518100E-02 |
| Caucasian-vs-AfricanAmerican |
7.746000E-01 |
| Caucasian-vs-Asian |
9.949800E-01 |
| AfricanAmerican-vs-Asian |
9.216000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95520000001448E-06 |
| Normal-vs-Female |
1.134040E-01 |
| Male-vs-Female |
9.316700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.472400E-02 |
| Normal-vs-Extreme_Weight |
4.56680000004983E-06 |
| Normal-vs-Obese |
1.495650E-02 |
| Normal-vs-Extreme_Obese |
9.188200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.413600E-01 |
| Normal_Weight-vs-Obese |
8.961800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.029600E-01 |
| Extreme_Weight-vs-Obese |
1.277780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.538200E-01 |
| Obese-vs-Extreme_Obese |
5.025800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.476400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.478430E-02 |
| Normal-vs-Age(61-80Yrs) |
6.86240000047356E-07 |
| Normal-vs-Age(81-100Yrs) |
1.620610E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.671800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.526000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.472000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.710490E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.406200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.286400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.63890000027101E-07 |
| Normal-VS-Type2 PRCC |
1.927530E-02 |
| Normal-VS-KIRP CIMP |
9.619200E-01 |
| Normal-VS-Unclassified PRCC |
2.119500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.071240E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.840500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.505200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.727400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.303200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.734830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.73700000000365E-05 |
| Normal-vs-N1 |
6.345400E-01 |
| Normal-vs-N2 |
1.123800E-03 |
| N0-vs-N1 |
7.563200E-03 |
| N0-vs-N2 |
5.842000E-01 |
| N1-vs-N2 |
1.123870E-03 |
|
|
